Max Healthcare Institute Limited

Max Healthcare Institute Limited announced it received confirmation from Kalinga Hospital Ltd., a subsidiary, of the allotment of 50,21,212 equity shares on a rights basis, representing an infusion of Rs 87.87 crore, increasing Max Healthcare’s shareholding in Kalinga Hospital Ltd. from approximately 58.28% to approximately 66.15%.

Max Healthcare Institute Limited announced that its Nomination & Remuneration Committee approved the allotment of 33,765 equity shares with a face value of Rs 10 each to eligible employees under the Max Healthcare Institute Limited - Employee Stock Option Scheme 2022. The allotment, which occurred on September 4, 2026, increased the company’s paid-up equity share capital to Rs 973,31,02,510 and total issued share capital to 97,33,10,251 equity shares.

Max Healthcare Institute Limited announced that its Renewable Energy and Subsidiary Investment Committee approved an additional investment of Rs 87.87 crore by way of subscription to equity shares on a rights basis in Kalinga Hospital Ltd., a subsidiary, to support capital expenditure, modernization, and general corporate requirements, with the transaction expected to be completed within the next 15 days.

Max Healthcare Institute Ltd share price softened by 3.08% to Rs 1008.0 after the company's net profit slipped by 5.63% to Rs 322.96 crore, while revenue from operations gained 10.42% to Rs 2366.17 crore in Q2FY26 over Q1FY26. The market capitalization of Hospital industry group stocks on BSE stood at Rs 5.19 lakh crore, gaining 7.53%. It has eased by 2% over last one week and soared by 26.76% in last one month while the market capitalization of Max Healthcare Institute Ltd has slipped by 6.23% and 4% in the same period respectively. Profit before tax (PBT) of Max Healthcare Institute Ltd stood at Rs 436.31 crore in Q2 FY26, rising 8.96% year-on-year, and declining 6.09% quarter-on-quarter. EBITDA came in at Rs 558 crore, advancing by 14.71% YoY and slipping 0.12% sequentially. Total expenses rose by 14.46% to Rs 1899.38 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 521.16 crore, surging by 20.27% YoY, while employee benefits expense was at Rs 388.18 crore, witnessing a strong rise of 14.08% YoY. For the TTM ended FY26, revenue from operations rose 19.14% to Rs 8373.45 crore, while net profit jumped 34.07% to Rs 1442.41 crore, compared to previous TTM. EBITDA soared by 177927% to Rs 2080.21 crore, and PBT registered a growth of 19.14% to Rs 1675.58 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 1633.32 crore in FY26, as against Rs 1459.31 crore in FY25. Max Healthcare Institute Ltd tumbled by 20.13% in last one year, underperforming the benchmark BSE Sensex which has softened by 2.83% during the same period.

Max Healthcare Institute Limited announced that its Nomination & Remuneration Committee approved the allotment of 3,048 equity shares with a face value of Rs 10 each to eligible employees following the exercise of vested stock options under the Max Healthcare Institute Limited - Employee Stock Option Scheme 2022. Consequently, the company's paid-up equity share capital increased to Rs 973,27,64,860 from Rs 973,27,34,380, with the total number of equity shares outstanding rising to 97,32,76,486.

Max Healthcare Institute Limited will hold a board meeting on Thursday, August 13, 2026, to consider and approve unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, according to a regulatory filing. The trading window for securities of the company will remain closed for designated persons and their immediate relatives until 48 hours after the financial results are declared.

Max Healthcare Institute announced that the 25th Annual General Meeting(AGM) of the company will be held on 30 July 2026.

Max Healthcare Institute has fixed 03 July 2026 as record date for determining the members entitled to receive the final dividend for the financial year 2025-26, if approved.

Max Healthcare Institute announced that the Board of Directors of the Company at its meeting held on 21 May 2026, inter alia, have recommended the final dividend of Rs 2 per equity Share (i.e. 20%) , subject to the approval of the shareholders.

Net profit of Max Healthcare Institute rose 7.28% to Rs 342.22 crore in the quarter ended March 2026 as against Rs 319.00 crore during the previous quarter ended March 2025. Sales rose 12.21% to Rs 2142.89 crore in the quarter ended March 2026 as against Rs 1909.74 crore during the previous quarter ended March 2025. For the full year,net profit rose 34.07% to Rs 1442.41 crore in the year ended March 2026 as against Rs 1075.88 crore during the previous year ended March 2025. Sales rose 19.14% to Rs 8373.45 crore in the year ended March 2026 as against Rs 7028.46 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales2142.891909.74 12 8373.457028.46 19 OPM %28.3026.79 -26.7926.30 - PBDT587.60503.33 17 2170.351839.42 18 PBT464.58402.50 15 1723.821480.00 16 NP342.22319.00 7 1442.411075.88 34 Powered by Capital Market - Live